[Fully possible to reduce the costs of hypertension treatment]

Lakartidningen. 2009 Jun;106(23):1558-62.
[Article in Swedish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / economics
  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage
  • Angiotensin-Converting Enzyme Inhibitors / economics
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / economics*
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / economics
  • Cost Savings
  • Cost-Benefit Analysis
  • Diuretics / administration & dosage
  • Diuretics / economics
  • Drug Costs
  • Humans
  • Hypertension / drug therapy
  • Hypertension / economics*
  • Outcome Assessment, Health Care
  • Practice Patterns, Physicians' / economics
  • Sweden

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics